Angtai Microfine Medical Technology (Formerly Ontai Microfine)
At a glance
- Status
- Operational
- Founded
- 2022
- Headquarters
- China
- Open positions
- None listed
- Dealroom signal
- 27.0/100
- Industry
- Health, Robotics
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Medical Robots, Surgical Equipment, Collaborative Robots, Surgical Robots, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Sep 2022 | $28M | $110M | Lingang Blue Bay Fund · Qiming Venture Partners · Proxima Ventures · Ruihua | ↗ |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
- LFLingang Blue Bay Fund
Qiming Venture Partners
Proxima Ventures- RURuihua
- XCXinyi Capital
- TCTaifu Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Angtai Microfine Medical Technology (Formerly Ontai Microfine) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Angtai Microfine Medical Technology (Formerly Ontai Microfine)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







